2Marehetti M, Barosi G, Balestri F, et al. Low dose thalidomide ameliorates cytopenias and splenomegaly in myeolfibrosis with myeloid [J]. J Clin Oncol, 2004,22(3) :424-431.
4Chong CR, Sullivan DJ Jr. New uses for old drugs [ J ]. Nature, 2007,448 (7154) :645-646.
5Anargyrou K, Dimopoulos MA, Sezer O, et al. Novel anti-myeloma agents and angiogenesis [ J ]. Leuk Lymphoma, 2008,49 ( 4 ) : 677-689.
6Tosi P, Zamagni E, Cellini C, et al. Neurological toxicity of long- term ( > lyr) thalidomide therapy in patients with multiple myeloma [J]. Eur J Haematol, 2005,74(3):212-216.
7Mileshkin L, Stark R, Day B, et al. Development of neuropathy in patients with myeloma treated with thalidomide: patterns of occurrence and the role of electrophysiologic monitoring [ J ]. J Clin Oncol, 2006, 24 (27) :4507-4514.
